Comparing Daridorexant vs Lemborexant
| Daridorexant | Lemborexant |
|
|---|
| Daridorexant | Lemborexant |
|
|---|---|---|
|
Prescription only
Prescribed for Insomnia. Daridorexant may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Insomnia. Lemborexant may also be used for purposes not listed in this medication guide. |
Related suggestions Insomnia
|
| More about Daridorexant | More about Lemborexant | |
| Ratings & Reviews | ||
|
Daridorexant has an average rating of 5.4 out of 10 from a total of 168 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 43% reported a negative effect. |
Lemborexant has an average rating of 5.3 out of 10 from a total of 300 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 45% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Daridorexant side effects |
View all Lemborexant side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Quviviq | Dayvigo | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
8 hours |
19 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 680 drugs are known to interact with Daridorexant:
|
A total of 464 drugs are known to interact with Lemborexant:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
||
| Disease Interactions | ||
| First Approval Date | ||
|
January 07, 2022 |
December 20, 2019 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Ativan
Ativan is a benzodiazepine used to treat anxiety disorders or anxiety associated with depression ...
Benadryl
Benadryl is an antihistamine and is used to treat sneezing, runny nose, itching and other ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Ambien
Ambien (zolpidem) is a prescription sedative used to treat insomnia, helping you fall asleep and ...
Lunesta
Lunesta is a sedative and is used to treat insomnia. Lunesta's effects typically begin within 30 ...
Eszopiclone
Eszopiclone (brand name Lunesta) is a sedative and is used to treat insomnia. Eszopiclone's effects ...
Temazepam
Temazepam is used to treat insomnia (trouble sleeping). Learn about side effects, interactions and ...
Doxepin
Doxepin is used for anxiety, depression, insomnia, irritable bowel syndrome, major depressive ...
Zolpidem
Zolpidem is a sedative-hypnotic medicine used for the short-term treatment of insomnia (trouble ...
Diphenhydramine
Diphenhydramine is an antihistamine used to treat sneezing, runny nose, itching, hives and other ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.